Literature DB >> 3029011

Effects of defined medium, fetal bovine serum, and human serum on growth and chemosensitivities of human breast cancer cells in primary culture: inference for in vitro assays.

J T Emerman, E E Fiedler, A W Tolcher, P M Rebbeck.   

Abstract

We compared the effects of defined medium, fetal bovine serum (FBS) and human serum (HuS) on the growth and responses to chemotherapeutic agents of human breast cancer cells in primary culture. Normal and tumor tissues were dissociated to small aggregates and single cells and seeded onto collagen-gel-coated wells in defined medium or medium supplemented with 5% FBS or 5% HuS. In all cases examined, defined medium and medium containing HuS were superior to medium containing FBS in supporting growth of both normal and tumor cell cultures. However, cultures in defined medium showed an initial cell loss. Cells from the same tumor cultured in different media varied in their responses to chemotherapeutic agents. In light of these results, medium supplemented with HuS, which promoted attachment of these cells in culture and stimulated their growth, should be the most appropriate nutrient environment for determining the effects of therapeutic agents on cells as it most closely resembles the in vivo situation. Because there were also variations in growth rates and chemosensitivities of tumor cells cultured in different human serum samples, we suggest that optimal conditions in which to culture these cells include the serum of the patient whose tumor is removed. This serum may provide host factors that influence cell growth and interact with exogenous factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029011     DOI: 10.1007/BF02623594

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  24 in total

1.  Fetal bovine serum: a multivariate standard.

Authors:  K V Honn; J A Singley; W Chavin
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

2.  Growth of normal and malignant human mammary epithelial cells in culture.

Authors:  W L Kirkland; N S Yang; T Jorgensen; C Longley; P Furmanski
Journal:  J Natl Cancer Inst       Date:  1979-07       Impact factor: 13.506

3.  Growth of human mammary epithelial cells on collagen gel surfaces.

Authors:  N S Yang; D Kube; C Park; P Furmanski
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

4.  Growth inhibitors in plasma derived human serum.

Authors:  D A Pigott; M A Grimaldi; M L Dell'Aquila; E V Gaffney
Journal:  In Vitro       Date:  1982-07

5.  Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations.

Authors:  C A Bertelsen; V K Sondak; B D Mann; E L Korn; D H Kern
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

6.  Significance of three-dimensional growth patterns of mammary tissues in collagen gels.

Authors:  E M Lawler; F R Miller; G H Heppner
Journal:  In Vitro       Date:  1983-08

7.  In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays.

Authors:  C Roobol; H C Sips; J Theunissen; G Atassi; J L Bernheim
Journal:  J Natl Cancer Inst       Date:  1984-03       Impact factor: 13.506

8.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract.

Authors:  S L Hammond; R G Ham; M R Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Glycosaminoglycan synthesis by subpopulations of epithelial cells from a mammary adenocarcinoma.

Authors:  J C Angello; K G Danielson; L W Anderson; H L Hosick
Journal:  Cancer Res       Date:  1982-06       Impact factor: 12.701

10.  Effect of cell shape change on the function and differentiation of rabbit mammary cells in culture.

Authors:  M T Haeuptle; Y L Suard; E Bogenmann; H Reggio; L Racine; J P Kraehenbuhl
Journal:  J Cell Biol       Date:  1983-05       Impact factor: 10.539

View more
  8 in total

1.  Human mammary epithelial cells in primary culture reflect c-myc and c-erbB-2 gene copy number in tissue.

Authors:  J T Emerman; S L Wilson; D A Wilkinson; D M Moore; P M Rebbeck
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

2.  Routine culturing of normal, dysplastic and malignant human mammary epithelial cells from small tissue samples.

Authors:  J T Emerman; D A Wilkinson
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

3.  In vitro sensitivity testing of human breast cancer cells to hormones and chemotherapeutic agents.

Authors:  J T Emerman; A W Tolcher; P M Rebbeck
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Human adipose-derived stromal cells stimulate autogenous skeletal repair via paracrine Hedgehog signaling with calvarial osteoblasts.

Authors:  Benjamin Levi; Aaron W James; Emily R Nelson; Shuli Li; Michelle Peng; George W Commons; Min Lee; Benjamin Wu; Michael T Longaker
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

5.  The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells.

Authors:  J A Claudio; J T Emerman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  In vitro screening of crude extracts and pure metabolites obtained from marine invertebrates for the treatment of breast cancer.

Authors:  J Stingl; R J Andersen; J T Emerman
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Estrogen receptor, progesterone receptor, interleukin-6 and interleukin-8 are variable in breast cancer and benign stem/progenitor cell populations.

Authors:  Robynn V Schillace; Amy M Skinner; Rodney F Pommier; Steven O'Neill; Patrick J Muller; Arpana M Naik; Juliana E Hansen; SuEllen J Pommier
Journal:  BMC Cancer       Date:  2014-09-30       Impact factor: 4.430

8.  Tissue Specific Differentiation of Human Chondrocytes Depends on Cell Microenvironment and Serum Selection.

Authors:  Annemarie Ecke; Anne-Helen Lutter; Jenny Scholka; Anna Hansch; Roland Becker; Ursula Anderer
Journal:  Cells       Date:  2019-08-19       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.